Subscribe
shutterstock_607718810_vchal
vchal / Shutterstock.com
14 November 2019EuropeRory O'Neill

Merck and Evotec strike CRISPR licensing deal

Merck has agreed to license its CRISPR gene-editing technology to German biotech company Evotec.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Sigma-Aldrich submits CRISPR petition at USPTO
23 July 2019   Merck KGaA-owned Sigma-Aldrich has petitioned the US Patent and Trademark Office to open an interference proceeding between its own pending CRISPR-Cas9 patents and patents awarded to the University of California, Berkeley.
Big Pharma
EU General Court sides with Merck in TM opposition
21 November 2019   A German individual has lost an appeal before the tribunal of the EU General Court, after his trademark registration was opposed by Merck.
Americas
USITC investigates grey market IVF products
14 April 2020   The US International Trade Commission is investigating ‘grey market’ in vitro fertilisation products intended for the Turkish market, following a trademark complaint from German pharmaceutical company Merck KGaA.


Editor's picks

Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024

Editor's picks

Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024

More on this story

Americas
USITC investigates grey market IVF products
14 April 2020   The US International Trade Commission is investigating ‘grey market’ in vitro fertilisation products intended for the Turkish market, following a trademark complaint from German pharmaceutical company Merck KGaA.
Americas
Sigma-Aldrich submits CRISPR petition at USPTO
23 July 2019   Merck KGaA-owned Sigma-Aldrich has petitioned the US Patent and Trademark Office to open an interference proceeding between its own pending CRISPR-Cas9 patents and patents awarded to the University of California, Berkeley.
Big Pharma
EU General Court sides with Merck in TM opposition
21 November 2019   A German individual has lost an appeal before the tribunal of the EU General Court, after his trademark registration was opposed by Merck.

More on this story

Americas
USITC investigates grey market IVF products
14 April 2020   The US International Trade Commission is investigating ‘grey market’ in vitro fertilisation products intended for the Turkish market, following a trademark complaint from German pharmaceutical company Merck KGaA.
Americas
Sigma-Aldrich submits CRISPR petition at USPTO
23 July 2019   Merck KGaA-owned Sigma-Aldrich has petitioned the US Patent and Trademark Office to open an interference proceeding between its own pending CRISPR-Cas9 patents and patents awarded to the University of California, Berkeley.
Big Pharma
EU General Court sides with Merck in TM opposition
21 November 2019   A German individual has lost an appeal before the tribunal of the EU General Court, after his trademark registration was opposed by Merck.

More features

Bayer gains exclusive licence for heart drug in Japan
EPO delivers key Novo Nordisk, GSK and Inhibrx rulings
McGuireWoods expands team with ex-Novo Nordisk GC
Paul, Weiss swoops for senior duo from Weil, Gotshal
UPC bans Meril Life Sciences from selling infringing heart valve
SCOTUS denies Alvogen unit's appeal to sell Bausch Xifaxan generic
Kathi Vidal to rejoin previous firm as partner following USPTO departure
GSK triumphs in EPO appeal, revoking Pfizer patent